The challenge
As competitive intensity increased across interventional cardiology and interventional radiology, differentiation became more difficult to sustain. Competitors were advancing integrated portfolios, value-based messaging, and more coordinated engagement strategies across clinical and economic stakeholders.
The company lacked a fact-based understanding of how it was perceived at the call point level and which commercial levers most influenced vendor selection. Variability in representative effectiveness, inconsistent articulation of economic value, and limited clarity on portfolio adjacency opportunities further constrained performance.
With two high-profile launches approaching, leadership needed to determine how to sharpen positioning, elevate field execution, and align launch investments with longer-term strategic priorities.
The solution
The company engaged BCE Consulting to conduct a comprehensive commercial strategy and launch readiness assessment using its Commercial Differentiators Framework, evaluating performance across product reliability, case support, training, portfolio breadth, contracting, pricing, representative competency, and omnichannel engagement.
The team combined structured market feedback with internal performance data to develop a call point-specific view of competitive standing. Customers were segmented into actionable personas based on clinical influence, economic authority, and engagement preferences. Procedural growth trends were mapped against the existing portfolio to identify high-proximity expansion opportunities.
Launch strategy was redesigned across the full lifecycle from pre-launch through post-launch sustainment. Messaging was tailored to persona-specific value drivers, economic narratives were strengthened, and field enablement was aligned to the moments that matter most in the adoption curve.
The results
The engagement delivered a step change in commercial clarity and execution discipline.
A call point specific commercial scorecard provided leadership with a transparent benchmark of competitive performance and a prioritized improvement roadmap. Persona-driven value propositions enabled more precise engagement across interventional cardiology and interventional radiology stakeholders.
Structured launch playbooks equipped field teams with clear guidance on targeting, value articulation, and objection management. As a result, the client:
- Focused training investments on the highest-impact capability gaps
- Activated key opinion leaders to reinforce clinical credibility
- Deployed economic storytelling tools to support value-based discussions
- Strengthened representative effectiveness at critical decision points
Beyond the immediate launches, BCE defined portfolio expansion pathways and organizational enablers required to sustain competitive advantage. The company emerged with a cohesive, data-driven commercial strategy positioned to drive durable growth in an increasingly complex interventional market.
